Eli Lilly Launches Mounjaro in India
– Mounjaro (tirzepatide), a diabetes and weight loss drug, officially launched in India.
Approved by Indian Drug Regulator– Approved by the Central Drugs Standard Control Organisation (CDSCO) for use in India.
💉 What is Mounjaro?– A GLP-1 receptor agonist that helps control blood sugar and promotes weight loss.– Originally developed for type 2 diabetes, now used for obesity treatment too.
What is Mounjaro (tirzepatide)?A dual-action injectable that helps control blood sugar & reduce weight.
By 2035, 11% of Indian adults may be obese.Mounjaro steps in to fight the epidemic. Real hope for Indians with:✔️ Type 2 Diabetes✔️ Obesity✔️ Insulin resistance
📈 India’s Rising Obesity Challenge– Around 11% of Indian adults expected to be obese by 2035.– Launch addresses growing health burden of diabetes and obesity.
🌍 Part of Global Expansion– Eli Lilly expanding into India, China, Brazil, and Mexico by 2026.– Over $23 billion invested globally to boost production capacity.
🏭 Boost for Indian Pharma Market– Major pharma companies like Sun Pharma, Biocon, and Cipla now eyeing the space.– Novo Nordisk’s Wegovy expected in India by 2026.
🧠 Impact on Patient– Offers new hope for millions with type 2 diabetes and obesity in India.– Available through prescription, likely in major metros first.
💡 How Mounjaro Work– Mimics two hormones: GLP-1 and GIP.– Enhances insulin secretion, reduces appetite, and slows digestion.– Proven to aid in significant weight loss in clinical trials.
📊 Clinical Result– Patients lost up to 20% of body weight in global trials.– Shown to outperform older drugs like Ozempic and Wegovy in some studies.
💰 Pricing in India– Yet to be officially disclosed.– Expected to be premium-priced, though possibly more affordable than in the West.
🌐 Global Success Story– Mounjaro is already a blockbuster drug in the U.S.– Contributed to Eli Lilly becoming world's most valuable pharma company.
🏥 Availability– Will be rolled out in major hospitals and pharmacies across India.– Prescription-only, with guidance from endocrinologists or diabetologists.
🚨 Side Effects to Know– Common side effects: nausea, vomiting, diarrhea.– Rare: pancreatitis or gallbladder issues.– Not recommended for pregnant women or type 1 diabetics.
🔮 Future of Weight-Loss Treatments in India– India set to become a key battleground for weight-loss therapies.– Demand expected to skyrocket with lifestyle-related diseases on the rise.